Viruses

Overview of Viruses

    Viruses are non-living entities, consisting of either DNA or RNA enclosed in a protein shell called a capsid. Some possess a viral envelope derived from the host cell membrane. They cannot reproduce independently, requiring a host cell for replication, making them obligate pathogens. Most viruses range in size from 50 to 200 nm.

Virus Structure

    Viruses are self-assembling nanoparticles maintained by weak non-covalent bonds. Effective virus disassembly can be achieved with soap and water, which disrupt these weak interactions.

Virus Mode of Operation

    Viruses penetrate host cells to utilize cellular machinery for the replication of their genetic material. They commonly transmit through respiratory droplets, vectors, or fomite contact. Virus attachment is specific to host cell types, influenced by genetic diversity.

Virus Life Cycle

    Upon entering a host, viruses may enter either the lytic or lysogenic cycle. In the lytic cycle, the virus hijacks the host cell to replicate and then bursts out, while in the lysogenic cycle, viral DNA integrates with the host DNA, allowing dormant persistence that can reactivate later. Examples include herpes and chickenpox viruses.

Viral Specificity

    Viruses can be species-specific, targeting specific organisms, like measles in humans or broader ranges, such as the West Nile virus. Notably, approximately 5-8% of human DNA originates from viruses, highlighting their historical impact on evolution.

Coronaviruses

    Coronaviruses, including SARS-CoV-2, are characterized by spike proteins on their surface, which facilitate host cell entry. SARS-CoV-2 is activated by the host enzyme furin and primarily binds to ACE2 receptors, which are potential therapeutic targets. Coronaviruses have existed for a long time and often originate from bats, with zoonotic transmission being a key factor in emerging infectious diseases.

Zoonotic Diseases and Future Pandemics

    Zoonotic diseases, which originate from animals, account for a significant proportion of new infectious diseases. Environmental changes due to human activities increase the likelihood of future pandemics.

Vaccination Mechanism

    Vaccinations stimulate the immune system to produce antibodies against pathogens, providing a blueprint for future immunity. They do not prevent viral entry but prepare the immune response to manage infections effectively. Understanding these mechanisms is crucial to navigating public health, especially during pandemics.

Vocabulary:

  • Viruses: Non-living entities, consisting of either DNA or RNA enclosed in a protein shell called a capsid.

  • Capsid: A protein shell that encloses the genetic material (DNA or RNA) of a virus.

  • Viral envelope: A membrane derived from the host cell membrane that some viruses possess.

  • Obligate pathogens: Entities, like viruses, that cannot reproduce independently and require a host cell for replication.

  • Lytic cycle: A viral life cycle where the virus hijacks the host cell to replicate its genetic material and then bursts out of the host cell.

  • Lysogenic cycle: A viral life cycle where viral DNA integrates with the host DNA, allowing for dormant persistence that can reactivate later.

  • Species-specific: Refers to viruses that target specific organisms.

  • Coronaviruses: A type of virus, including SARS-CoV-2, characterized by spike proteins on their surface which facilitate host cell entry.

  • Spike proteins: Proteins found on the surface of coronaviruses, such as SARS-CoV-2, that facilitate their entry into host cells.

  • Furin: A host enzyme that activates SARS-CoV-2, playing a role in its ability to enter cells.

  • ACE2 receptors: Specific receptors on host cells that SARS-CoV-2 primarily binds to, making them potential therapeutic targets.

  • Zoonotic diseases: Infectious diseases that originate from animals and can be transmitted to humans.

  • Vaccinations: A process that stimulates the immune system to produce antibodies against pathogens, creating a blueprint for future immunity.